ACRO BIOMEDICAL CO., LTD. Shareholders' Equity
ACRO BIOMEDICAL CO., LTD. (ACBM) had Shareholders' Equity of -$444.79 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$444.79K.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$427.24K.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$386.96K.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$432.62K.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$444.79K 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$427.24K 10-Q · filed 2026-08-14 |
| 2025-12-31 | -$386.96K 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$432.62K 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$317.52K 10-Q · filed 2026-08-14 |
| 2025-03-31 | -$303.91K 10-Q · filed 2026-08-14 |
| 2024-12-31 | -$294.97K 10-Q · filed 2026-08-14 |
| 2024-09-30 | -$285.50K 10-Q · filed 2025-11-10 |
| 2024-06-30 | -$276.40K 10-Q · filed 2025-11-10 |
| 2024-03-31 | -$267.31K 10-Q · filed 2025-11-10 |
| 2023-12-31 | -$257.01K 10-K · filed 2026-02-11 |
| 2023-09-30 | -$239.61K 10-Q · filed 2025-07-23 |
| 2023-06-30 | $339.65K 10-Q · filed 2025-07-23 |
| 2023-03-31 | $410.90K 10-Q · filed 2025-07-23 |
| 2022-12-31 | $486.37K 10-K · filed 2025-07-24 |
| 2022-09-30 | $492.16K 10-Q · filed 2025-07-11 |
| 2022-06-30 | $574.89K 10-Q · filed 2025-07-11 |
| 2022-03-31 | $643.22K 10-Q · filed 2025-07-11 |
| 2021-12-31 | $643.71K 10-K · filed 2025-07-18 |
| 2021-09-30 | $568.22K 10-Q · filed 2022-11-21 |
| 2021-06-30 | $640.21K 10-Q · filed 2022-11-21 |
| 2021-03-31 | $628.88K 10-Q · filed 2022-11-21 |
| 2020-12-31 | $685.87K 10-K · filed 2023-07-21 |
| 2020-12-30 | $685.87K 10-Q · filed 2021-11-22 |
| 2020-09-30 | $745.48K 10-Q · filed 2021-11-22 |
| 2020-06-30 | $817.02K 10-Q · filed 2021-11-22 |
| 2020-03-31 | $879.80K 10-Q · filed 2021-11-22 |
| 2019-12-31 | $798.24K 10-K · filed 2022-04-15 |
| 2019-09-30 | $873.67K 10-K · filed 2021-04-02 |
| 2019-06-30 | $948.00K 10-Q · filed 2020-11-17 |
| 2019-03-31 | $998.22K 10-Q · filed 2020-11-17 |
| 2018-12-31 | $1.17M 10-K · filed 2021-04-02 |
| 2018-09-30 | $1.24M 10-K · filed 2021-04-02 |
| 2018-06-30 | $777.32K 10-Q · filed 2019-08-14 |
| 2018-03-31 | $661.01K 10-Q · filed 2019-08-14 |
| 2017-12-31 | $591.56K 10-Q · filed 2019-08-14 |
| 2017-09-30 | $511.33K 10-KT · filed 2020-03-27 |
| 2017-06-30 | -$28.16K 10-Q · filed 2017-08-11 |
| 2017-03-31 | -$16.28K 10-Q · filed 2017-05-22 |
| 2016-12-31 | -$22.21K 10-Q · filed 2017-02-14 |
| 2016-09-30 | -$14.79K 10-K · filed 2018-12-28 |
| 2016-06-30 | -$8.67K 10-Q · filed 2016-08-03 |
| 2016-03-31 | $8.46K 10-Q · filed 2016-05-13 |
| 2015-09-30 | $28.64K 10-K/A · filed 2018-01-16 |
| 2014-09-30 | $3.92K 10-K · filed 2016-12-16 |